ARA290 (16 mg)

Description

ARA290 (16 mg) is a research peptide studied for its potential anti-inflammatory, tissue-protective, and nerve-regenerating properties. Derived from erythropoietin (EPO), ARA290 has been modified to provide cytoprotective and anti-inflammatory effects without stimulating red blood cell production. It has gained interest in research focused on chronic pain, neuropathy, autoimmune conditions, and tissue repair.

How It Works
ARA290 works by selectively binding to the innate repair receptor (IRR), triggering tissue protection, reducing inflammation, and promoting nerve regeneration. Unlike erythropoietin, ARA290 does not activate erythropoiesis, avoiding the risk of increased red blood cell counts. Research studies suggest that ARA290 may improve neuropathic pain, support vascular repair, and promote healthy immune responses.

Key Benefits of ARA290:

• Supports nerve regeneration and pain relief in research studies
• Promotes tissue protection and vascular repair
  
• Demonstrates anti-inflammatory properties without affecting red blood cells
  
• Aids in the study of neuropathy and autoimmune conditions
  
• May support healing in diabetic neuropathy models
  
• Investigated for potential benefits in chronic inflammatory diseases

Usage and Safety:

• Peptide Name: ARA290
• Quantity: 16 mg
• Purity: ≥ 99%
• Form: Lyophilized powder
• Use: For laboratory research only. Not for human consumption.

ARA290 is utilized in laboratory settings to explore its effects on nerve repair, inflammation, autoimmune disorders, and chronic pain management. It is not approved for human or veterinary use.

Disclaimer: This product is for research purposes only and is not intended for human or veterinary use.